Opinion Survey of the Cardiologists in Bulgaria Regarding Therapy with Acetylsalicylic Acid, Clopidogrel and Acenocoumarol in Patients Undergoing Dental Extractions

Purpose: Cardiovascular diseases are leading cause of mortality and disability worldwide. Major role in the treatment and prophylaxis of these diseases and their complications have antiplatelet and anticoagulation drugs. Routine practice in the past was an interruption of antiplatelet and anticoagulant medication before dental extraction. Today most authors and dental associations recommend maintaining therapeutic levels of antithrombotic drugs in single or multiple teeth extractions due to the fact that the risk of serious thromboembolic complications outweighs the risk of bleeding. The aim of the present study is to determine the opinion and approach of the General Practitioners in Bulgaria regarding therapy with Aspirin, Clopidogrel and Acenocoumarol in patients undergoing dental extractions.Material and Method: 282 General Practitioners were interviewed for their approach to the antithrombotic therapy with Acetylsalicylic acid (Aspirin) Clopidogrel (Plavix, Trombex) and Acenocoumarol (Sintrom) in patients undergoing dental extractions.Results: There is no consensus and an established protocol on the cessation of Acetylsalicylic acid (Aspirin) Clopidogrel (Plavix, Trombex) and Acenocoumarol (Sintrom), and for what period of time before dental extraction.Conclusion: Among General Practitioners in Bulgaria there is no approved protocol regarding administration of Acetylsalicylic acid (Aspirin) Clopidogrel (Plavix, Trombex) and Acenocoumarol (Sintrom) in patients undergoing teeth extraction.